Trigeminal neuralgia is a chronic pain condition that affects the trigeminal nerve, which carries sensation from face to brain.
This report contains market size and forecasts of Trigeminal Neuralgia Treatment in Global, including the following market information:
Global Trigeminal Neuralgia Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Trigeminal Neuralgia Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Drug Based Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Trigeminal Neuralgia Treatment include Allergan Plc, Biogen, Inc., Kineta Inc., Merz Pharma GmbH & Co., Trigemina Inc., Abbott Laboratories, Pfizer Inc., GlaxoSmithKline Plc. and Novartis. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Trigeminal Neuralgia Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Trigeminal Neuralgia Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Trigeminal Neuralgia Treatment Market Segment Percentages, by Type, 2021 (%)
Drug Based
Surgery
Global Trigeminal Neuralgia Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Trigeminal Neuralgia Treatment Market Segment Percentages, by Application, 2021 (%)
Hospitals
Clinic
Others
Global Trigeminal Neuralgia Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Trigeminal Neuralgia Treatment Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Trigeminal Neuralgia Treatment revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Trigeminal Neuralgia Treatment revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Allergan Plc
Biogen, Inc.
Kineta Inc.
Merz Pharma GmbH & Co.
Trigemina Inc.
Abbott Laboratories
Pfizer Inc.
GlaxoSmithKline Plc.
Novartis